Literature DB >> 22429269

Predictors of seizures during pregnancy in women with epilepsy.

Sanjeev V Thomas1, Unnikrishnan Syam, J Sucharitha Devi.   

Abstract

We aimed to characterize the seizure pattern during pregnancy in a large cohort of women with epilepsy (WWE) and identify possible predictors of seizure relapse during pregnancy. We recorded the antiepileptic drug (AED) use and seizure frequency for WWE during the prepregnancy month and pregnancy. The seizure profile was correlated with the clinical details and seizure type as abstracted from the clinical records maintained in the registry. Of the 1,297 pregnancies in WWE with complete seizure data, 47.8% were seizure-free during pregnancy. Seizure relapse was highest during the three peripartum days. Women with partial seizures-had higher risk of relapse (odds ratio [OR] 1.6, 95% confidence interval [CI] 1.2-2.0) than those with generalized seizures. They had two peaks of seizure relapse (second to third month and sixth month). Those with generalized seizures had one peak at first trimester. Those who were on polytherapy had increased risk of seizures (OR 2.98, 95% CI 2.3-3.9) when compared to those on monotherapy. Those who had seizures in the prepregnancy month had higher risk (OR 15, 95% CI 9-25.1) of seizures during pregnancy when compared to those who were seizure-free during that period. On multiple logistic regression, prepregnancy seizure was the most important predictor of seizures during pregnancy. Wiley Periodicals, Inc.
© 2012 International League Against Epilepsy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22429269     DOI: 10.1111/j.1528-1167.2012.03439.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  21 in total

Review 1.  Treatment of Juvenile Myoclonic Epilepsy in Patients of Child-Bearing Potential.

Authors:  Anna Serafini; Elizabeth Gerard; Pierre Genton; Arielle Crespel; Philippe Gelisse
Journal:  CNS Drugs       Date:  2019-03       Impact factor: 5.749

2.  How do you treat epilepsy in pregnancy?

Authors:  Ilena C George
Journal:  Neurol Clin Pract       Date:  2017-08

3.  Quantification of neurosteroids during pregnancy using selective ion monitoring mass spectrometry.

Authors:  Kurt D Pennell; Mark A Woodin; Page B Pennell
Journal:  Steroids       Date:  2014-12-23       Impact factor: 2.668

4.  Variations in Seizure Frequency During Pregnancy and Postpartum by Epilepsy Type.

Authors:  P Emanuela Voinescu; Alexa N Ehlert; Camden P Bay; Stephanie Allien; Page B Pennell
Journal:  Neurology       Date:  2021-12-10       Impact factor: 9.910

5.  The impact of maternal epilepsy on delivery and neonatal outcomes.

Authors:  Shahla Melikova; Hijran Bagirova; Sharif Magalov
Journal:  Childs Nerv Syst       Date:  2019-11-30       Impact factor: 1.475

6.  Prospective, case-control study on the effect of pregnancy on seizure frequency in women with epilepsy.

Authors:  Angela La Neve; Giovanni Boero; Teresa Francavilla; Marzia Plantamura; Giusy De Agazio; Luigi M Specchio
Journal:  Neurol Sci       Date:  2014-07-29       Impact factor: 3.307

7.  Epilepsy: Indian perspective.

Authors:  Nandanavana Subbareddy Santhosh; Sanjib Sinha; Parthasarathy Satishchandra
Journal:  Ann Indian Acad Neurol       Date:  2014-03       Impact factor: 1.383

Review 8.  Medical management of epileptic seizures: challenges and solutions.

Authors:  Anand K Sarma; Nabil Khandker; Lisa Kurczewski; Gretchen M Brophy
Journal:  Neuropsychiatr Dis Treat       Date:  2016-02-24       Impact factor: 2.570

Review 9.  Managing Epilepsy in Women.

Authors:  Elizabeth E Gerard; Kimford J Meador
Journal:  Continuum (Minneap Minn)       Date:  2016-02

10.  Changes in Seizure Frequency and Antiepileptic Therapy during Pregnancy.

Authors:  Page B Pennell; Jacqueline A French; Ryan C May; Elizabeth Gerard; Laura Kalayjian; Patricia Penovich; Evan Gedzelman; Jennifer Cavitt; Sean Hwang; Alison M Pack; Maria Sam; John W Miller; Steffanie H Wilson; Carrie Brown; Angela K Birnbaum; Kimford J Meador
Journal:  N Engl J Med       Date:  2020-12-24       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.